Skip to main content
. Author manuscript; available in PMC: 2013 Dec 13.
Published in final edited form as: Neuroscience. 2012 Sep 19;226:427–440. doi: 10.1016/j.neuroscience.2012.09.030

Fig. 5.

Fig. 5

Mean distance traveled (±SEM) during the 80-min behavioral testing session on PD 18 (n = 8 per group). Rats were given IP injections of SCH23390/sulpiride (D1/D2 protected) or saline/saline (nonprotected) prior to EEDQ or DMSO infusions. At the conclusion of time block 8 (indicated by the second dashed line), EEDQ- and DMSO-treated preweanling rats received bilateral infusions of NPA (0, 10, or 20 μg).

† Significantly different from rats in the DMSO-nonprotected group (collapsed across time blocks).

‡ Significantly different from DMSO-treated rats.

* Significantly different from rats in the same treatment conditions infused with 0 μg NPA (collapsed across time blocks 9–16).

^ Significantly different from rats in the other treatment conditions infused with 10 or 20 μg NPA (collapsed across time blocks 9–16).